SignalChem社はイノベーティブで高品質なヒト組み換え細胞シグナル伝達製品の研究・開発・生産に特化したバイオテクノロジー企業です。SignalChem社は長年にわたり、細胞シグナル伝達、分子生物学、タンパク質生化学のコア技術を活用して、2,000以上の機能性タンパク質製品を生み出しており、特にタンパク質キナーゼ、疾患関連変異キナーゼ、脂質キナーゼ、エピジェネティック酵素、神経変性疾患関連酵素およびタンパク質などの高活性ヒト組み換えシグナル伝達酵素を製造するグローバルリーダーとしての地位を確立しています。SignalChem社はライフサイエンスの基礎研究を発展させ、創薬開発を促進させるための効果的な研究ツールを開発することで、世界中のアカデミア、製薬企業、バイオテクノロジー企業の研究者をサポートしております。
> SignalChem社 COVID-19関連 製品最新ミニカタログはこちら
2019-nCoV(SARS-CoV-2)関連研究用試薬
リコンビナントタンパク質
製品名 | 製品番号 | タグ | 発現ホスト | 配列 | 製品情報 | 関連資料 |
---|---|---|---|---|---|---|
3CLpro, Active | C19CL-G241H | His | E.coli | Full length | 5 µg | |
10 µg | ||||||
20 µg | ||||||
50 µg | ||||||
NSP10/NSP16, Active | C19NS-E301H | His | E.coli | Full length | 10 µg | |
20 µg | ||||||
50 µg | ||||||
NSP14, Active | C19NS-E311H | His | E.coli | 5925-6452 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
NSP7 Protein | C19N7-E541H | His | E.coli | Full length | 10 µg | |
20 µg | ||||||
50 µg | ||||||
NSP8 Protein | C19N8-E541H | His | E.coli | Full length | 10 µg | |
20 µg | ||||||
50 µg | ||||||
Nucleocapsid (N) Protein | C19NP-G242H | His | E.coli | Full length | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
PLpro, Active | C19PL-G241H | His | E.coli | 1564-1882 | 5 µg | |
10 µg | ||||||
20 µg | ||||||
50 µg | ||||||
RdRp, Active | C19RP-G241H | His | E.coli | Full length | 5 µg | |
10 µg | ||||||
20 µg | ||||||
50 µg | ||||||
Spike protein RBD (K417N, E484K, N501Y) | C19SD-G232H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (K417N, E484K, N501Y), HRP conjugated | C19SD-G232D | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (K417T) | C19SD-G239H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (K417T, E484K and N501Y) | C19SD-G231AH | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (K417T, E484K, N501Y), HRP conjugated | C19SD-G231AD | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (N439K) | C19SD-G233H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (L452R) | C19SD-G235H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
2019-nCoV Spike Protein RBD (L452R, T478K) | C19SD-G231FH | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (L452R, T478K), HRP conjugated | C19SD-G231FD | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (L452R, E484Q) | C19SD-G231DH | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (L452R, E484Q), HRP conjugated | C19SD-G231DD | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (L452Q, F490S) | C19SD-G231MH | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (Y453F) | C19SD-G234H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (S477N) | C19SD-G238H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (E484K) | C19SD-G237H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (N501Y) | C19SD-G231H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD (N501Y), HRP conjugated | C19SD-G231D | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD, Fc Tag | C19SD-G241F | Fc | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD, HIS Tag | C19SD-G241H | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein RBD, HRP conjugated | C19SD-G241D | His | CHO cells | 319-541 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1 (T19R, G142D, del157-158, L452R, T478K, D614G, P681R) | C19S1-G231LH | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1 (Δ69-70, Y453F, D614G) | C19S1-G231AH | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
100 µg | ||||||
Spike protein S1 (Δ69-70 Δ144 N501Y A570D D614G P681H) | C19S1-G239H | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
SSpike protein S1 (T95I, G142D, E154K, L452R, E484Q, D614G, P681R) | C19S1-G231KH | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1 (D614G) | C19S1-G231H | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1 (P681H) | C19S1-G232H | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1, Fc Tag | C19S1-G241F | Fc | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S1, HIS Tag | C19S1-G241H | His | CHO cells | 16-685 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Spike protein S2, Fc Tag | C19S2-G241F | Fc | CHO cells | 686-1212 | 100 µg | |
500 µg | ||||||
Spike RBD-N Protein Chimera | C19NSD-G242H | His | CHO cells | 319-541 & 237-419 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Human ACE2 (18-615) Protein | A51C2-G342F | Fc | CHO cells | 18-615 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Dog ACE2 (18-739) Protein | A53C2-G341F | Fc | CHO cells | 18-739 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Rat ACE2 (18-740) Protein | A52C2-G341F | Fc | CHO cells | 18-739 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
Human ACE2 (19-740) Protein | A51C2-G341F | Fc | CHO cells | 19-740 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
MERS Spike Protein RBD | MERSD-G241F | Fc | CHO cells | 377-588 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
SARS-CoV Spike Protein RBD | SARSD-G241F | Fc | CHO cells | 318-510 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
SARS-CoV Spike Protein S1, Fc Tag | SARS1-G241F | Fc | CHO cells | 14-680 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
SARS-CoV Spike Protein S1, HIS Tag | SARS1-G241H | His | CHO cells | 14-680 | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
2019-nCoV Spike protein RBD (Omicron) | C19SD-G231OH | His | CHO cells | - | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg | ||||||
2019-nCoV Spike protein S1 (Omicron) | C19S1-G231OH | His | CHO cells | - | 10 µg | |
20 µg | ||||||
50 µg | ||||||
100 µg |
抗体
製品名 | 製品番号 | ターゲット | アイソタイプ | 製品情報 | 関連資料 |
---|---|---|---|---|---|
Anti N-Protein hIgG Antibody | C19NP-60H | 2019-nCoV N-Protein SARS-CoV N-Protein | Human, IgG | 20 µg | |
100 µg | |||||
Anti N-Protein hIgG Antibody, HRP conjugated | C19NP-60DH | 2019-nCoV N-Protein SARS-CoV N-Protein | Human, IgG | 20 µg | |
100 µg | |||||
Anti Spike Protein hIgG Antibody | C19S1-60H | 2019nCoV spike protein SARS-CoV spike protein | Human, IgG1 | 20 µg | |
100 µg | |||||
Anti Spike Protein hIgG Antibody, HRP conjugated | C19S1-60DH | 2019-nCoV spike protein SARS-CoV spike protein | Human, IgG1 | 20 µg | |
100 µg | |||||
Anti-Spike Protein hIgA Antibody | C19S1-A60H | 2019-nCoV spike protein SARS-CoV spike protein | Human, IgA | 20 µg | |
100 µg | |||||
Anti-Spike Protein hIgM Antibody | C19S1-M60H | 2019-nCoV spike protein SARS-CoV spike protein | Human, IgM | 20 µg | |
100 µg | |||||
Anti Spike Protein hIgG Antibody | C19S1-61H | 2019-nCoV spike protein SARS-CoV spike protein | Human, IgG1 | 20 µg | |
100 µg | |||||
Anti-Spike Protein mIgG Antibody | C19S1-61MH | 2019nCoV spike protein SARS-CoV spike protein | Human Fab-mouse Fc | 20 µg | |
100 µg |
ナノボディ
製品名 | 製品番号 | ターゲット | アイソタイプ | 製品情報 | 関連資料 |
---|---|---|---|---|---|
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-654L | 2019-nCoV spike protein | Llama VHH | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-644HL | 2019-nCoV spike protein | Llama VHH-Human IgG Fc | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-653L | 2019-nCoV spike protein | Llama VHH | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-643HL | 2019-nCoV spike protein | Llama VHH-Human IgG Fc | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-652L | 2019-nCoV spike protein | Llama VHH | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-642HL | 2019-nCoV spike protein | Llama VHH-Human IgG Fc | 20 µg | |
100 µg | |||||
Anti-2019-nCoV Spike Protein Nanobody (NBX20010) | C19S1-641HL | 2019-nCoV spike protein | Llama VHH-Human IgG Fc | 20 µg | |
100 µg |
Binding (Bind) / Neutralizing (NT) 活性一覧
501Y.V1* | 501Y.V2** | WT RBD | ||||
---|---|---|---|---|---|---|
Bind | NT | Bind | NT | Bind | NT | |
NBX20014 | Y | Y | N | N | Y | Y |
NBX20025 | Y | N | N | N | Y | Y |
NBX20038 | Y | Y | Y | Weak | Y | Y |
NBX20010 | Y | Weak | Y | N | Y | Weak |
*501Y.V1 activity vs. C19SD-G231H:RBD(N501Y) **501Y.V2 activity vs. C19SD-G232H:RBD(K417N, E484K, N501Y) |
ELISAキット
製品名 | 製品番号 | ターゲット | サンプル | 製品情報 | 関連資料 |
---|---|---|---|---|---|
2019-nCoV S1 Protein ELISA Kit | C19SD-876 | 2019-nCoV spike protein | complex biological samples | 96 tests | |
2019-nCoV High Sensitivity S1 Protein ELISA Kit | C19S1-876 | 2019nCoV spike protein | complex biological samples | 96 tests | |
2019-nCoV S1 Human IgG ELISA Kit | C19S1-877 | 2019-nCoV S1 Human IgG | Serum, Plasma | 96 tests | |
2019-nCoV S1 Human IgA ELISA Kit | C19S1-A877 | 2019-nCoV S1 Human IgA | Serum, Plasma | 96 tests | |
2019-nCoV S1 Human IgM ELISA Kit | C19S1-M877 | 2019-nCoV S1 Human IgM | Serum, Plasma | 96 tests | |
2019-nCoV S1 Human IgG-IgA-IgM ELISA Kit | C19S1-P877 | 2019-nCoV S1 Human IgG-IgA-IgM | Serum, Plasma | 96 tests | |
2019-nCoV N-S1 Human IgG ELISA Kit | C19NS1-877 | 2019-nCoV N & S1 Human IgG | Serum, Plasma | 96 tests | |
2019-nCoV N-S1 Human IgA ELISA Kit | C19NS1-A877 | 2019-nCoV N & S1 Human IgA | Serum, Plasma | 96 tests | |
2019-nCoV N-S1 Human IgM ELISA Kit | C19NS1-M877 | 2019-nCoV N & S1 Human IgM | Serum, Plasma | 96 tests | |
2019-nCoV N-S1 Human IgG-IgA-IgM ELISA Kit | C19NS1-P877 | 2019-nCoV N & S1 Human IgG-IgA-IgM | Serum, Plasma | 96 tests | |
2019-nCoV Neutralization ELISA Kit | C19SD-N887 | circulating neutralizing antibodies or proteins | Serum, Plasma | 96 tests |
製品の特徴
2019-nCoV S1 Protein detection Kit
- 複合生体試料中の2019-nCoVスパイクタンパク質を検出
- 組み換えヒトACE2タンパク質がコート済み
- キャリブレーションコントロールが含まれており、
定量的に測定が可能
2019-nCoV S1 Human IgG Kit
- 血清または複合生体試料中のヒト抗nCoVスパイクタンパク質S1 IgGを検出
- 組み換え2019-nCoVスパイクタンパク質RBDがコート済み
- 陽性および陰性コントロールが含まれており、信頼性の高いデータを保証します
アッセイフロー
2019-nCoV S1 Protein detection Kit

2019-nCoV S1 Human IgG Kit

データ



構成品
2019-nCoV S1 Protein detection Kit
バイアルID | 構成品名 | 容量 |
---|---|---|
CP02-A51C2 | ACE2 Coated Plate | 1 plate |
SS01-09 | Stop Solution | 6 mL |
C19SD-CAL0 | 2019-nCoV Spike protein RBD Calibrator 0 | 1 mL |
C19SD-CAL1 | 2019-nCoV Spike protein RBD Calibrator 1 | 1 mL |
C19SD-CAL2 | 2019-nCoV Spike protein RBD Calibrator 2 | 1 mL |
C19SD-CAL3 | 2019-nCoV Spike protein RBD Calibrator 3 | 1 mL |
C19S1-61DH | Anti-nCoV S antibody, HRP | 10 mL |
CS02-506 | One-Step TMB Substrate | 10 mL |
E01-09 | nCoV-ELISA Sample Dilution Buffer | 2 x 10 mL |
WB20-09 | Wash Buffer, 20X | 2 x 15 mL |
2019-nCoV S1 Human IgG Kit
バイアルID | 構成品名 | 容量 |
---|---|---|
CP03-C19SD | 2019-nCoV Spike Protein RBD Coated Plate | 1 plate |
SS01-09 | Stop Solution | 6 mL |
C19S1-NEG | anti-2019-nCoV S1 NEG Control | 1 mL |
C19S1-POS | anti-2019-nCoV S1 POS Control | 1 mL |
H38-63DG | Anti-Human IgG Fab Detection Ab | 10 mL |
CS02-506 | One-Step TMB Substrate | 10 mL |
WB20-09 | Wash Buffer, 20X | 2 x 15 mL |
E02-09 | nCoV IgG Sample Dilution Buffer | 2 x 10 mL |